Effects of sex hormones on basophil histamine release in recurrent idiopathic anaphylaxis.
A subset of patients with recurrent anaphylaxis experience ovarian hormone-related exacerbations. Symptoms in several of these women may be provoked by gonadotropins or progesterone (P) and improved by ovarian suppression, with long-term remissions noted in several patients after oophorectomy. Since adverse reactions to P might explain this association, the effects of P and estrogen on basophil histamine release from these patients were studied. Eight patients and 10 control subjects were examined. Neither estrogen nor P caused histamine release from the basophils of patients or control subjects. Moreover, anti-IgE-induced histamine release was not influenced by P or estrogen. Attempts to culture basophils for 24 hours revealed that basophil preparations from eight of 10 normal subjects but only three of eight patients retained the capacity to respond to anti-IgE after 24 hours (p = 0.088). Culture with dexamethasone reduced anti-IgE-induced histamine release in all subjects, and the possibility that P might interfere with the effect of dexamethasone was also studied. P failed to affect dexamethasone-induced reduction of basophil histamine release. Therefore, P and estradiol appear to have no effect on basophils from either patients with hormone-related exacerbations of anaphylaxis or from control subjects.
D000293:Adolescent; D000328:Adult; D000707:Anaphylaxis / Q000378:metabolism*; D001491:Basophils / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D011374:Progesterone / Q000494:pharmacology
D012739:Gonadal Steroid Hormones; D011374:Progesterone; D004958:Estradiol